|
Jul 21
|
Here's Why We Think Corcept Therapeutics (NASDAQ:CORT) Is Well Worth Watching
|
|
Jul 17
|
Madrigal (MDGL) Moves 10.9% Higher: Will This Strength Last?
|
|
Jul 17
|
3 Reasons CORT is Risky and 1 Stock to Buy Instead
|
|
Jul 14
|
Corcept Submits New Drug Application for Relacorilant as a Treatment for Patients with Platinum-Resistant Ovarian Cancer
|
|
Jun 27
|
Aurinia (AUPH) Surges 7.5%: Is This an Indication of Further Gains?
|
|
Jun 26
|
5 Insightful Analyst Questions From Corcept’s Q1 Earnings Call
|
|
Jun 24
|
Corcept ALS Drug Shows Significant Survival Benefit Despite Missed Primary Endpoint
|
|
Jun 23
|
Corcept Presents Data from Treatment Phase of CATALYST Trial at American Diabetes Association’s 85th Scientific Sessions with Simultaneous Publication in Diabetes Care
|
|
Jun 23
|
June 2025's High Insider Ownership Growth Stocks
|
|
Jun 23
|
Do Its Financials Have Any Role To Play In Driving Corcept Therapeutics Incorporated's (NASDAQ:CORT) Stock Up Recently?
|
|
May 26
|
1 Growth Stock with All-Star Potential and 2 to Avoid
|
|
May 23
|
Discover 3 Growth Stocks With Insider Ownership Up To 28%
|
|
May 22
|
Branded Pharmaceuticals Stocks Q1 Results: Benchmarking Corcept (NASDAQ:CORT)
|
|
May 11
|
Why Corcept Therapeutics (CORT) Is Among the Best Performing Healthcare Stocks to Buy Now
|
|
May 8
|
1 Small-Cap Stock Worth Your Attention and 2 to Question
|
|
May 7
|
Corcept Therapeutics price target lowered to $135 from $150 at Truist
|
|
May 6
|
Q1 2025 Corcept Therapeutics Inc Earnings Call
|
|
May 6
|
Corcept Therapeutics (NasdaqCM:CORT) Reports US$21M Q1 Net Income Lowers EPS
|
|
May 6
|
CORT's Q1 Earnings In Line With Estimates, Revenues Lag, Shares Fall
|
|
May 6
|
Corcept Therapeutics Inc (CORT) Q1 2025 Earnings Call Highlights: Revenue Growth Amid ...
|